The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis


CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN), is a transmembrane glycoprotein that is highly expressed in tumor cells, particularly melanoma cells, and plays critical roles in tumor cell metastasis through the regulation of matrix metalloprotease (MMP) expression. In this study, we identified Fyn as a novel interacting protein of CD147. Fyn is a member of the Src family of nonreceptor tyrosine kinases that regulates diverse physiological processes, such as T lymphocyte differentiation, through the TCR signaling pathway. Our findings demonstrated that Fyn directly phosphorylates CD147 at Y140 and Y183. Two phosphospecific antibodies against Y140 and Y183 were developed to validate the phosphorylation of CD147 by Fyn. Moreover, the CD147-FF (Y140F/Y183F) mutation impaired the interaction between CD147 and GnT-V, leading to decreased CD147 glycosylation and membrane recruitment. In addition, CD147-FF significantly blocked MMP-9 expression as well as cell migration. Moreover, we found that Fyn is overexpressed in clinical melanoma tissues as well as in melanoma cell lines. Knockdown of Fyn expression markedly attenuated the malignant phenotype of melanoma cells in vitro and in vivo through downregulation of CD147 phosphorylation, indicating that Fyn/CD147 is a potential target molecule in melanoma treatment. Finally, through virtual screening, we identified amodiaquine as a potential inhibitor targeting the Fyn/CD147 axis. Amodiaquine treatment dramatically inhibited the phosphorylation of CD147 by Fyn, thus attenuating melanoma cell growth and invasion in vitro and in vivo, suggesting that amodiaquine is a promising inhibitor for melanoma treatment.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: CD147 is phosphorylated by Fyn at Y140 and Y183.
Fig. 2: Fyn is highly expressed in melanoma.
Fig. 3: Knockdown of Fyn inhibits melanoma cell growth.
Fig. 4: Knockdown of Fyn inhibits melanoma invasiveness and metastasis in vitro and in vivo.
Fig. 5: Phosphorylation of CD147 affects its biological function through the regulation of glycosylation.
Fig. 6: Amodiaquine is a novel inhibitor targeting Fyn for melanoma treatment.


  1. 1.

    Watanabe A, Hoshino D, Koshikawa N, Seiki M, Suzuki T, Ichikawa K. Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia. PLoS Comput Biol. 2013;9:e1003086.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Zhang J, Huang X, Wang L. Pioglitazone inhibits the expression of matrix metalloproteinase-9, a protein involved in diabetes-associated wound healing. Mol Med Rep. 2014;10:1084–8.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Moro N, Mauch C, Zigrino P. Metalloproteinases in melanoma. Eur J Cell Biol. 2014;93:23–9.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep. 2008;10:439–46.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Kuphal S, Bosserhoff A. Recent progress in understanding the pathology of malignant melanoma. J Pathol. 2009;219:400–9.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Vultur A, Herlyn M. SnapShot: melanoma. Cancer Cell 2013;23:706–e1.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Su J, Gao T, Jiang M, Wu L, Zeng W, Zhao S, et al. CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma. Oncotarget 2016;7:64778–84.

    PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Huang W, Luo WJ, Zhu P, Tang J, Yu XL, Cui HY, et al. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J. 2013;449:437–48.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Saito YD, Jensen AR, Salgia R, Posadas EM. Fyn: a novel molecular target in cancer. Cancer 2010;116:1629–37.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Susa M, Rohner D, Bichsel S. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases. Biochem Biophys Res Commun. 1996;220:729–34.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc Natl Acad Sci USA. 1995;92:8891–5.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Zeng W, Su J, Wu L, Yang D, Long T, Li D, et al. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation. Curr Mol Med. 2014;14:163–73.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Zhou J, Zhu P, Jiang JL, Zhang Q, Wu ZB, Yao XY, et al. Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1. BMC Cell Biol. 2005;6:25.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Su J, Chen X, Kanekura T. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett. 2009;273:140–7.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Mauris J, Woodward AM, Cao Z, Panjwani N, Argueso P. Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3. J Cell Sci. 2014;127(Pt 14):3141–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Wu JB, Shen L, Qiu L, Duan QW, Luo ZG, Dong XX. Reversal effect of GnT-V on the radioresistance of human nasopharyngeal carcinoma cells by alteration beta1, 6-GlcNAc branched N-glycans. Int J Clin Exp Pathol. 2015;8:9901–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Cui J, Huang W, Wu B, Jin J, Jing L, Shi WP, et al. N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin beta1 and promotes HCC metastasis. J Pathol. 2018;245:41–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Gruszewska E, Chrostek L. The alterations of glycosylation in malignant diseases. Pol Merkur Lekarski. 2013;34:58–61.

    PubMed  Google Scholar 

  19. 19.

    Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget 2014;5:2736–49.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Liao CG, Kong LM, Song F, Xing JL, Wang LX, Sun ZJ, et al. Characterization of basigin isoforms and the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion. Mol Cell Biol. 2011;31:2591–604.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Kanekura T, Chen X. CD147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci. 2010;57:149–54.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer. 2002;99:520–8.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Long T, Su J, Tang W, Luo Z, Liu S, Liu Z, et al. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells. Cancer Lett. 2013;339:93–101.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Rey MC, Bonamigo RR, Cartell A, Furian R, Bonfa R, Bonfa R. MMP-2 and TIMP-2 in cutaneous melanoma: association with prognostic factors and description in cutaneous metastases. Am J Dermatopathol. 2011;33:413–4.

    PubMed  Article  Google Scholar 

  25. 25.

    Cotignola J, Reva B, Mitra N, Ishill N, Chuai S, Patel A, et al. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet. 2007;8:10.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  26. 26.

    Liang X, Lu Y, Wilkes M, Neubert TA, Resh MD. The N-terminal SH4 region of the Src family kinase Fyn is modified by methylation and heterogeneous fatty acylation: role in membrane targeting, cell adhesion, and spreading. J Biol Chem. 2004;279:8133–9.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Elias D, Ditzel HJ. Fyn is an important molecule in cancer pathogenesis and drug resistance. Pharm Res. 2015;100:250–4.

    CAS  Article  Google Scholar 

  28. 28.

    Miyamoto Y, Tamano M, Torii T, Kawahara K, Nakamura K, Tanoue A, et al. Data supporting the role of Fyn in initiating myelination in the peripheral nervous system. Data Brief. 2016;7:1098–105.

    PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Lang V, Semichon M, Michel F, Brossard C, Gary-Gouy H, Bismuth G. Fyn membrane localization is necessary to induce the constitutive tyrosine phosphorylation of Sam68 in the nucleus of T lymphocytes. J Immunol. 1999;162:7224–32.

    CAS  PubMed  Google Scholar 

  30. 30.

    Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev. 2009;228:9–22.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Schaeuble K, Hauser MA, Singer E, Groettrup M, Legler DF. Cross-talk between TCR and CCR7 signaling sets a temporal threshold for enhanced T lymphocyte migration. J Immunol. 2011;187:5645–52.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Yadav V, Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog. 2011;50:346–52.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Li K, Zhang Y, Zhang Y, Jiang W, Shen J, Xu S, et al. Tyrosine kinase Fyn promotes osteoarthritis by activating the beta-catenin pathway. Ann Rheum Dis. 2018;77:935–43.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Baillat G, Siret C, Delamarre E, Luis J. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta. 2008;1783:2323–31.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Yu XL, Jiang JL, Li L, Feng Q, Xu J, Chen ZN. The glycosylation characteristic of hepatoma-associated antigen HAb18G/CD147 in human hepatoma cells. Int J Biochem Cell Biol. 2006;38:1939–45.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Li JH, Huang W, Lin P, Wu B, Fu ZG, Shen HM, et al. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Sci Rep. 2016;6:35210.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Fan J, Wang S, Yu S, He J, Zheng W, Zhang J. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147. Glycoconj J. 2012;29:323–34.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato W, Miwa Y, et al. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol. 2009;20:1565–76.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Tang Y, Cong X, Wang S, Fang S, Dong X, Yuan Y, et al. GnT-V promotes chemosensitivity to gemcitabine in bladder cancer cells through beta1,6 GlcNAc branch modification of human equilibrative nucleoside transporter 1. Biochem Biophys Res Commun. 2018;503:3142–8.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Huang B, Wu Q, Ge Y, Zhang J, Sun L, Zhang Y, et al. Expression of N-acetylglucosaminyltransferase V in gastric cancer correlates with metastasis and prognosis. Int J Oncol. 2014;44:849–57.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Li B, Su S, Zhang MY, He L, Wang QD, He K. Effect of GnT-V knockdown on the proliferation, migration and invasion of the SMMC7721/R human hepatocellular carcinoma drug-resistant cell line. Mol Med Rep. 2016;13:469–76.

    PubMed  Article  CAS  Google Scholar 

  42. 42.

    Huang B, Sun L, Cao J, Zhang Y, Wu Q, Zhang J, et al. Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells. Oncol Rep. 2013;29:2392–400.

    CAS  PubMed  Article  Google Scholar 

Download references


This work was financially supported by the Major Projects of International Cooperation and Exchanges NSFC Grant No. 81620108024; Grant No. 81572679, 81773341, 31770774, 81572677, 81830096 from the National Natural Science Foundation; the Strategy-Oriented Special Project of Central South University in China (ZLXD2017003); the Provincial Major Project of basic or Applied Research in Natural Science, Guangdong Provincial, Education Department (2016KZDXM038) and the China Postdoctoral Science Foundation (2019M652808).

Author information



Corresponding authors

Correspondence to Xiang Chen or Cong Peng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Huang, Z., Guo, Y. et al. The phosphorylation of CD147 by Fyn plays a critical role for melanoma cells growth and metastasis. Oncogene 39, 4183–4197 (2020).

Download citation

Further reading